Opportunity Information: Apply for PA 16 259
Apply for PA 16 259
- The HHS-NIH11 in the health sector is offering a public funding opportunity titled "Inclusion of Mobile/e-Consents for Alzheimer's Disease Research (Admin Supp)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866,.
- This funding opportunity was created on May 16, 2016 and posted on May 16, 2016.
- Applicants must submit their applications by Aug 15, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity titled "Inclusion of Mobile/e-Consents for Alzheimer's Disease Research (Admin Supp)" (Funding Opportunity Number PA 16 259) is a National Institute on Aging (NIA) administrative supplement program intended to help existing Alzheimer's disease clinical research projects add or expand the use of mobile, electronic informed consent (often called e-consent or mobile e-consent). The core purpose is to support practical, innovative approaches for developing and implementing electronic consenting methods that can be used in real-world Alzheimer's and related dementia research settings, with the broader goal of improving how participants are informed, enrolled, and retained in clinical studies.
This opportunity is offered by the U.S. Department of Health and Human Services under the National Institutes of Health (Agency: HHS-NIH11), and it falls under the health funding activity category with CFDA numbers 93.866. Because it is an administrative supplement, it is designed to provide additional funds to support a specific enhancement or add-on to an existing NIH-supported project rather than to fund an entirely new, stand-alone research grant. In practice, that typically means the supplement would be used to build, test, and roll out electronic consent tools and workflows within the framework of an already funded Alzheimer's disease clinical research award.
Funding is relatively targeted and limited in size, reflecting its supplement nature. The award ceiling is listed as $100,000, and the program anticipated making about 2 awards. The application deadline for this particular announcement was August 15, 2016 (original and current closing dates match), and the announcement was created and posted on May 16, 2016, indicating a short window between posting and closing typical of many administrative supplement opportunities.
A wide range of organizations were eligible to apply. Eligible applicants included multiple levels of government (state, county, city or township, and special district governments), public and state-controlled institutions of higher education, private institutions of higher education, independent school districts, federally recognized Native American tribal governments, other tribal organizations, public housing authorities/Indian housing authorities, nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in the nonprofit category listed), for-profit organizations other than small businesses, small businesses, and other entities as described in the additional eligibility language referenced by the notice. This broad eligibility reflects the diverse ecosystem involved in Alzheimer's clinical research, including universities, health systems, nonprofits, and industry partners that may be running or supporting clinical studies.
The main activity supported by the supplement is the development and implementation of mobile e-consent strategies for Alzheimer's disease clinical research. While the announcement text is brief, the intent is clear: to modernize or improve the consent process using electronic, mobile-enabled approaches, which can include things like multimedia consent materials, interactive comprehension checks, remote consenting to reduce the burden of travel, and more standardized and auditable consent documentation. In Alzheimer's disease research specifically, electronic consent approaches can be especially valuable because studies often involve older adults, caregivers, and legally authorized representatives, and may need clear documentation of consent capacity, proxy consent, re-consent over time, and participant understanding. The supplement mechanism is meant to help investigators and research teams operationalize these tools within ongoing studies, potentially improving participant inclusion and study efficiency.
In short, PA 16 259 was a small, competitive NIA administrative supplement opportunity aimed at accelerating the adoption of mobile electronic consent methods in Alzheimer's clinical research, offering up to $100,000 per award, expecting roughly two awards, and allowing applications from a broad set of public, private, nonprofit, and for-profit entities that are positioned to incorporate e-consent innovations into active NIH-funded research projects.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Inclusion of Mobile/e-Consents for Alzheimer's Disease Research (Admin Supp)" and the Funding Opportunity Number is PA 16 259.
Which agency is offering this funding opportunity?
This opportunity is offered by the U.S. Department of Health and Human Services under the National Institutes of Health (Agency: HHS-NIH11), specifically through the National Institute on Aging (NIA).
What type of funding mechanism is this?
This is an administrative supplement. It is intended to add funds to an existing NIH-supported project to support a specific enhancement or add-on, rather than to fund a brand-new, stand-alone research grant.
What is the main purpose of this administrative supplement?
The purpose is to help existing Alzheimer's disease clinical research projects add or expand the use of mobile, electronic informed consent (often called e-consent or mobile e-consent). The broader goal is to improve how participants are informed, enrolled, and retained in clinical studies by supporting practical and innovative electronic consenting approaches that work in real-world research settings.
What kinds of activities does the supplement support?
The supplement supports the development and implementation of mobile e-consent strategies within existing Alzheimer's disease clinical research projects. Examples described include multimedia consent materials, interactive comprehension checks, remote consenting to reduce travel burden, and more standardized and auditable consent documentation and workflows.
Is this funding meant to create a new research project?
No. Because it is an administrative supplement, it is meant to support an enhancement to an already funded NIH-supported Alzheimer's disease clinical research award, such as building, testing, and rolling out electronic consent tools within the framework of the existing project.
What research area does this opportunity focus on?
It focuses on Alzheimer's disease clinical research and related dementia research settings, specifically in the context of informed consent processes.
Why might mobile/e-consent be especially relevant for Alzheimer's and related dementia research?
The opportunity highlights that Alzheimer's disease research often involves older adults, caregivers, and legally authorized representatives. Electronic consent approaches can be valuable in these settings by helping with clear documentation of consent capacity, proxy consent, re-consent over time, and participant understanding, while also supporting more efficient and inclusive study operations.
How much funding is available per award?
The award ceiling is listed as $100,000.
How many awards were expected to be made?
The program anticipated making about 2 awards.
When was the application deadline?
The application deadline (original and current closing date) was August 15, 2016.
When was the opportunity posted?
The announcement was created and posted on May 16, 2016.
What funding activity category does this fall under?
It falls under the health funding activity category.
What CFDA number is associated with this opportunity?
The CFDA number listed is 93.866.
Who is eligible to apply?
Eligibility is broad and includes: state governments; county governments; city or township governments; special district governments; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; federally recognized Native American tribal governments; other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in the nonprofit category referenced); for-profit organizations other than small businesses; small businesses; and other entities as described in the additional eligibility language referenced by the notice.
Does the opportunity allow applications from both nonprofit and for-profit organizations?
Yes. The eligibility list includes nonprofits (with or without 501(c)(3) status) and for-profit organizations (including small businesses and for-profits other than small businesses), as well as a wide range of government and education entities.
What kinds of projects is this supplement intended to help?
It is intended to help teams that are already running NIH-supported Alzheimer's disease clinical research projects incorporate or expand electronic consenting tools and workflows, with an emphasis on practical implementation in real-world study settings.
What is the overall goal beyond building the technology?
The stated aim is not just to create tools, but to improve the consent process in ways that support better participant information, enrollment, and retention in Alzheimer's disease and related dementia clinical studies.
Browse more opportunities from the same agency: HHS-NIH11
Browse more opportunities from the same category: Health
Next opportunity: Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color – Jurisdictional Sites
Previous opportunity: NOTICE OF INTENT TO AWARD - Wheeling National Heritage Area
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 16 259
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 16 259) also looked into and applied for these:
| Funding Opportunity |
|---|
| Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color – Jurisdictional Sites Apply for HRSA 16 189 Funding Number: HRSA 16 189 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R01) Apply for PAR 16 265 Funding Number: PAR 16 265 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R34) Apply for PAR 16 264 Funding Number: PAR 16 264 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01) Apply for PAR 16 262 Funding Number: PAR 16 262 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities Outside the United States Apply for CDC RFA IP16 1603 Funding Number: CDC RFA IP16 1603 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $400,000 |
| NHLBI Career Transition Award for Intramural Fellows (K22) Apply for PAR 16 267 Funding Number: PAR 16 267 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization Apply for CDC RFA IP16 1606 Funding Number: CDC RFA IP16 1606 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $2,000,000 |
| Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States Apply for CDC RFA IP16 1604 Funding Number: CDC RFA IP16 1604 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $250,000 |
| NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 16 269 Funding Number: PAR 16 269 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development (R01) Apply for RFA AI 16 047 Funding Number: RFA AI 16 047 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03) Apply for PAR 16 268 Funding Number: PAR 16 268 Agency: HHS-NIH11 Category: Health Funding Amount: $50,000 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 16 270 Funding Number: PAR 16 270 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Planning Grant (R34) Apply for PAR 16 272 Funding Number: PAR 16 272 Agency: HHS-NIH11 Category: Health Funding Amount: $150,000 |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44) Apply for PAR 16 271 Funding Number: PAR 16 271 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Healthy Tomorrows Partnership for Children Program (HTPCP) Apply for HRSA 17 008 Funding Number: HRSA 17 008 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Improving Sexually Transmitted Disease Programs through Assessment, Assurance, Policy Development, and Prevention Strategies (STD AAPPS) Apply for CDC RFA PS14 140204CONT17 Funding Number: CDC RFA PS14 140204CONT17 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| CDC’s National Undergraduate Student Program: A Public Health Workplace Experience to Increase Student Interest in Public Health Apply for CDC RFA MN11 110106CONT16 Funding Number: CDC RFA MN11 110106CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Fogarty Global Health Training Program (D43) Apply for RFA TW 16 002 Funding Number: RFA TW 16 002 Agency: HHS-NIH11 Category: Health Funding Amount: $1,100,000 |
| Surveillance, intervention, and referral to services activities for infants with microcephaly or other adverse outcomes linked with the Zika virus Apply for CDC RFA DD16 1605 Funding Number: CDC RFA DD16 1605 Agency: HHS-CDC-NCBDDD Category: Health Funding Amount: $360,000 |
| Developing New Clinical Decision Support to Disseminate and Implement Patient-Centered Outcomes Research Findings (R18) Apply for PA 16 282 Funding Number: PA 16 282 Agency: HHS-AHRQ Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 16 259", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.